Sign in to my Account
Not a member? Join the CNS
Update your profile, manage education credits, set communication preferences, and more
< Return to CNS.org
Upon completion of this course, attendees will be able to:
- Define integrated diagnosis and identify the major changes in the WHO 2016 classification update and the potential clinical implications.
- Review the molecular sub classification of glioma and/or medulloblastoma and the purported impact on survival/tumor biology and common predictive and prognostic molecular markers in neuro-oncology.
- Analyze the findings of novel neurosurgical studies; critique the design and methodology of these studies.
- List important areas for further knowledge development and research.
- Identify the most important ongoing clinical trials studying targeted therapies for primary brain tumors.
Primary Brain Tumors—New WHO Classification for Gliomas
Overview of New WHO Classification for Gliomas
Maria Martinez-Lage Alvarez
Molecular Classification: Prognostic or Predictive?
Bob S. Carter
Neurosurgery in the Age of Molecular Medicine
Frederick F. Lang
Oral Abstract Presentations
Questions and Discussion
Daniel P. Cahill, Bob S. Carter, Frederick F. Lang
Find a Neurosurgeon